Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

APS1 and celiac patients reveal autoimmune amelogenesis imperfecta

ABSTRACT: APS1 and celiac patients reveal autoimmune amelogenesis imperfecta

PROVIDER: PRJNA930396 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

APS1 and celiac patients reveal autoimmune amelogenesis imperfecta

Project description:To investigate the dependence of amelogenesis imperfecta-related gene expression and ameloblast-related gene expression on Aire in the thymus, mTEChi from Aire+/+ and Aire-/- were sorted and subjected to bulk RNAseq.

2023-09-21 | GSE224247 | GEO

A human autoimmune organoid model reveals IL-7 function in celiac disease

Project description:A human autoimmune organoid model reveals IL-7 function in celiac disease

| PRJNA830541 | ENA

Project description:WES of amelogenesis imperfecta family

| PRJNA997257 | ENA

Transcription profiling of MIII celiac disease patients vs controls (M0) individuals

Project description:Comparison of MIII celiac disease patients to controls (M0) individuals.

2005-01-01 | E-MEXP-42 | biostudies-arrayexpress

OSTEOGENSIS IMPERFECTA

Project description:NGS DATA for OSTEOGENESIS IMPERFECTA affected patients

| PRJEB66424 | ENA

A human autoimmune organoid model reveals IL-7 function in celiac disease

Project description:In vitro models of autoimmunity are constrained by an inability to culture affected epithelium alongside the complex tissue-resident immune microenvironment. Celiac disease (CeD) is an autoimmune disease where dietary gluten-derived peptides bind the MHC- II molecules HLA-DQ2 or -DQ8 to initiate immune-mediated duodenal mucosal injury. Here, we generated air-liquid interface (ALI) duodenal organoids from endoscopic biopsies that preserve epithelium alongside native mesenchyme and tissue-resident immune cells as a unit without requiring reconstitution. The ALI organoid immune diversity spanned T, B, plasma, NK and myeloid cells with extensive T and B cell receptor repertoires. HLA-DQ2.5-restricted gluten peptides selectively instigated epithelial destruction in HLA-DQ2.5-expressing CeD patient organoids, which was antagonized by MHC-II or NKG2C/D blockade. Gluten epitopes stimulated a CeD organoid network response in lymphoid and myeloid subsets alongside anti-TG2 autoantibody production. Functional studies in CeD organoids revealed IL-7 as a novel gluten-inducible pathogenic modulator which regulated CD8+ T cell-NKG2C/D expression and was necessary and sufficient for epithelial destruction. Further, endogenous IL-7 was markedly induced in patient biopsies from active CeD versus remission disease, predominantly in lamina propria mesenchyme. By preserving epithelium alongside diverse immune populations, this human in vitro CeD model recapitulates gluten-dependent pathology, facilitates mechanistic investigation, and establishes proof-of-principle for organoid modeling of autoimmunity.

2024-07-12 | GSE200075 | GEO

RNA sequencing derived from intestinal biopsies from healthy controls and celiac disease patients

Project description:Aim: To compare the overall transcriptional profile in healthy controls and celiac disease patients. This dataset, was used to evaluate if our in vitro model (intestinal intraepithelial lymphocytes, desccribed in doi:10.1016/j.jaut.2020.10242 ) is representative of the transcriptional profile in the intestine under healthy or inflammatory conditions. Samples: Upper colonoscopy biopsies from 5 control and 11 celiac disease patients were taken, total RNA was extracted and RNA-sequencing was performed (without replicates)

2021-02-16 | GSE146190 | GEO

16S V3-V4 -based microbial profiling of duodenal mucosa samples obtained by esophagogastroduodenoscopy from patients affected by potential celiac disease and celiac disease

Project description:Potential celiac diseasase (PCD) is characterized by a positive celiac disease (CD) serology and a normal small intestinal mucosa. This particular condition is usually considered a clinical challenge because, although its diagnostic criteria are clear, many questions are still unsettled. Therefore, given that PCD is a valuable biological model of the pathway leading to small intestinal mucosal damage in genetically predisposed individuals, the aim of our study is to evaluate whether immunological, microbial and lipid signatures could better characterize the PCD from the CD condition.

2022-10-19 | GSE181070 | GEO

First Degree Relatives (FDRs) of Patients with Celiac Disease Harbour an Intestinal Transcriptomic Signature that Might Protect Them from Enterocyte Damage

Project description:Patients with Celiac Disease, first degree relatives of celiac patients and control groups displayed significant differential gene expression.

2019-03-21 | GSE112102 | GEO

Osteogenesis imperfecta

Project description:Sequencing of a Fleckvieh animal for dominant Osteogensis imperfecta

| PRJEB12324 | ENA